Letter to the Editor
Health technology assessment of new drugs for rare disorders in Canada: impact of disease prevalence and cost
Authors from the Canadian Agency for Drugs and Technologies in Health (CADTH) presented an analysis of submissions to the Common Drug Review (CDR) between 2004 and February 3, 2016 for drugs for rare disorders...
Orphanet Journal of Rare Diseases 2017 12:59
Published on: 23 March 2017